Pacific Biosciences
PACB
PACB
115 hedge funds and large institutions have $240M invested in Pacific Biosciences in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less capital invested
Capital invested by funds: $580M → $240M (-$340M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
91% less call options, than puts
Call options by funds: $213K | Put options by funds: $2.4M
Holders
115
Holding in Top 10
1
Calls
$213K
Puts
$2.4M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$20.2M | |
| 3 | +$3.4M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.6M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.04M |
Top Sellers
| 1 | -$44.5M | |
| 2 | -$25.2M | |
| 3 | -$14.1M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$8.73M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$7.78M |